ATLASense Biomed revolutionizes patient monitoring with REPHAEL, a wearable, non-invasive system that provides ICU-level continuous, real-time detection of clinical deterioration—starting with early sepsis. Unlike standard RPM solutions, REPHAEL delivers hospital-grade accuracy through a chest-worn biosensor and AI-driven alerts, enabling proactive care at the bedside or remotely. With regulatory approval and live deployments.